Sign in

CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company

Marker Therapeutics, Inc.

Sign in to watch
Ticker
MRKR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880277072
Phone
(713) 400-6400
Business address
2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
Former names
TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
  1. NT 10-K Other NT 10-K
  2. SC 13G Stake Amended Statement of Ownership
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. 8-K Event Material agreement · Agreement ended · Unregistered share sale · Regulation FD disclosure
  6. UPLOAD Other SEC-generated Letter
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. UPLOAD Other SEC-generated Letter
  10. 10-Q Report Quarterly Report
  11. NT 10-Q Other NT 10-Q
  12. 8-K Event Executive or director change
  13. 10-Q Report Quarterly Report
  14. NT 10-Q Other NT 10-Q
  15. 424B3 Offering Prospectus
  16. EFFECT Other Notice of Effectiveness
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. S-1/A Offering Registration Statement
  20. S-1/A Offering Registration Statement

Page 33 of 46 · 904 filings